Back

Characteristics and long-term outcomes of asymptomatic patients with hypertrophic cardiomyopathy

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Epidemiological trends in heart failure and cardiomyopathy Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Milind Desai

Cleveland Clinic, Cleveland (United States of America)

4 More presentations in this session

Presentation thumbnail
The optimal cut-off and integrative risk score for incident heart failure by Nt-proBNP among pre-HF (stages A and B) type 2 diabetes population - the DM-Heart study
Professor C. Hung (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Global, regional, and national burden of heart failure in young adults aged 15-49 years, 1990-2021: results from the global burden of disease study 2021
Doctor A. Xin (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Rare and common variant drivers of ischemic cardiomyopathy
Doctor K. Supriami (Boston, US)
Abstract Slides Video
Presentation thumbnail
Temporal trends in fatal and non-fatal heart failure admissions in Denmark from 1996 to 2022: A 25-year analysis of >180.000 patients with incident heart failure
Doctor C. Garred (Herlev, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiological trends in heart failure and cardiomyopathy
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Worse prognosis for sudden cardiac death events and progression to the burned-out phase in non-obstructive hypertrophic cardiomyopathy: insights from the REVEAL-HCM Registry
thumbnail
Congress Presentation
Comparisons in cardiovascular outcomes and mortality in patients diagnosed with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Efficacy and safety of long-term treatment with aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from FOREST-HCM

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources